Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867005990883295232 |
|---|---|
| author | Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi |
| author_facet | Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi |
| collection | Wiley Open Access |
| contents | Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC) Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi Cell Biochemistry and Function AbstractHepatocellular carcinoma (HCC) is one of the growing malignancies globally, affecting a myriad of people and causing numerous cancer‐related deaths. Despite therapeutic improvements in treatment strategies over the past decades, HCC still remains one of the leading causes of person‐years of life lost. Numerous studies have been conducted to assess the characteristics of HCC with the aim of predicting its prognosis and responsiveness to treatment. However, the identified biomarkers have shown limited sensitivity, and the translation of these findings into clinical practice has faced challenges. The development of sequencing techniques has facilitated the exploration of a wide range of genes, leading to the emergence of gene signatures. Although several studies assessed differentially expressed genes in normal and HCC tissues to find the unique gene signature with prognostic value, to date, no study has reviewed the task, and to the best of our knowledge, this review represents the first comprehensive analysis of relevant studies in HCC. Most gene signatures focused on immune‐related genes, while others investigated genes related to metabolism, autophagy, and apoptosis. Even though no identical gene signatures were found, NDRG1, SPP1, BIRC5, and NR0B1 were the most extensively studied genes with prognostic value. Finally, despite challenges such as the lack of consistent patterns in gene signatures, we believe that comprehensive analysis of pertinent gene signatures will bring us a step closer to personalized medicine in HCC, where treatment strategies can be tailored to individual patients based on their unique molecular profiles. 10.1002/cbf.3913 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/cbf.3913 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_cbf_3913 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC) Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi Cell Biochemistry and Function Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC) Atieh Pourbagheri‐Sigaroodi Fatemeh Fallah Davood Bashash Abdollah Karimi Cell Biochemistry and Function AbstractHepatocellular carcinoma (HCC) is one of the growing malignancies globally, affecting a myriad of people and causing numerous cancer‐related deaths. Despite therapeutic improvements in treatment strategies over the past decades, HCC still remains one of the leading causes of person‐years of life lost. Numerous studies have been conducted to assess the characteristics of HCC with the aim of predicting its prognosis and responsiveness to treatment. However, the identified biomarkers have shown limited sensitivity, and the translation of these findings into clinical practice has faced challenges. The development of sequencing techniques has facilitated the exploration of a wide range of genes, leading to the emergence of gene signatures. Although several studies assessed differentially expressed genes in normal and HCC tissues to find the unique gene signature with prognostic value, to date, no study has reviewed the task, and to the best of our knowledge, this review represents the first comprehensive analysis of relevant studies in HCC. Most gene signatures focused on immune‐related genes, while others investigated genes related to metabolism, autophagy, and apoptosis. Even though no identical gene signatures were found, NDRG1, SPP1, BIRC5, and NR0B1 were the most extensively studied genes with prognostic value. Finally, despite challenges such as the lack of consistent patterns in gene signatures, we believe that comprehensive analysis of pertinent gene signatures will bring us a step closer to personalized medicine in HCC, where treatment strategies can be tailored to individual patients based on their unique molecular profiles. 10.1002/cbf.3913 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC) |
| topic | Cell Biochemistry and Function |
| url | https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/cbf.3913 |